172 related articles for article (PubMed ID: 12827577)
21. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
22. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
23. Protamine-induced pulmonary venoconstriction in heparinized pigs.
Hakim TS; Picone A; Oleary CE; Camporesi EM
Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279
[TBL] [Abstract][Full Text] [Related]
24. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
[TBL] [Abstract][Full Text] [Related]
25. Effects of protamine on nitric oxide level in the pulmonary circulation.
Kalaycioğlu S; Sinci V; Erbaş D
Jpn Heart J; 1999 May; 40(3):335-8. PubMed ID: 10506855
[TBL] [Abstract][Full Text] [Related]
26. [Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin].
Cao Y; Shioi K; Narumiya C; Aoyama T; Mase T; Nagata Y
Kyobu Geka; 2000 May; 53(5):390-5. PubMed ID: 10808289
[TBL] [Abstract][Full Text] [Related]
27. Hydrocortisone pretreatment for attenuation of protamine-induced adverse hemodynamic reactions.
Baraka A; Choueiry P; Taha S; Yazbeck V; Chidiac G; Azar IA; Zughbi J
J Cardiothorac Vasc Anesth; 1995 Aug; 9(4):481-2. PubMed ID: 7579125
[No Abstract] [Full Text] [Related]
28. The effect of histamine-receptor blockade on the hemodynamic responses to protamine.
Parsons RS; Mohandas K
J Cardiothorac Anesth; 1989 Feb; 3(1):37-43. PubMed ID: 2520637
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary hypertension after heparin-protamine: roles of left-sided infusion, histamine, and platelet-activating factor.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Gutmann R; Hobbhahn J; Brendel W; Peter K
Anesth Analg; 1990 Dec; 71(6):637-44. PubMed ID: 2240637
[TBL] [Abstract][Full Text] [Related]
30. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
31. Effects of differing rates of protamine reversal of heparin anticoagulation.
Wakefield TW; Hantler CB; Wrobleski SK; Crider BA; Stanley JC
Surgery; 1996 Feb; 119(2):123-8. PubMed ID: 8571194
[TBL] [Abstract][Full Text] [Related]
32. Protamine dosage based on two titrations reduces blood loss after valve replacement surgery: a prospective, double-blinded, randomized study.
Guo Y; Tang J; Du L; Liu J; Liu RC; Liu X; Guo Y
Can J Cardiol; 2012; 28(5):547-52. PubMed ID: 22633184
[TBL] [Abstract][Full Text] [Related]
33. The heparin-protamine interaction. A review.
Carr JA; Silverman N
J Cardiovasc Surg (Torino); 1999 Oct; 40(5):659-66. PubMed ID: 10596998
[TBL] [Abstract][Full Text] [Related]
34. Noncardiogenic pulmonary edema immediately following rapid protamine administration.
Brooks JC
Ann Pharmacother; 1999 Sep; 33(9):927-30. PubMed ID: 10492491
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
[TBL] [Abstract][Full Text] [Related]
36. Protamine-associated hypotension in patients on hemodialysis: retrospective study and prevalence of antiprotamine antibodies.
Tsai YT; Chang LC; Lin YF; Tsai CS; Lai CH; Chen JS
Clin Nephrol; 2009 Aug; 72(2):122-8. PubMed ID: 19640369
[TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR.
Al-Kassou B; Kandt J; Lohde L; Shamekhi J; Sedaghat A; Tabata N; Weber M; Sugiura A; Fimmers R; Werner N; Grube E; Treede H; Nickenig G; Sinning JM
JACC Cardiovasc Interv; 2020 Jun; 13(12):1471-1480. PubMed ID: 32553337
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients].
Charnaia MA; Morozov IuA; Gladysheva VG; Isaeva AM
Anesteziol Reanimatol; 2006; (5):31-3. PubMed ID: 17184058
[TBL] [Abstract][Full Text] [Related]
39. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
[TBL] [Abstract][Full Text] [Related]
40. Effects of a paf-receptor antagonist on hemodynamics during and after cardiopulmonary bypass.
Nathan N; Mercury P; Denizot Y; Cornu E; Laskar M; Lathelize M; Arnoux B; Feiss P
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):647-52. PubMed ID: 8664454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
